Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277834 · ClinicalTrials.gov registry record
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 9
- Enrollment target
NCT02277834: Completed study, sponsored by University of Alabama at Birmingham.
NCT02277834 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02277834 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Currently, X-rays and blood tests often miss pancreatic cancer. In this study, we are collecting and studying the fluid produced by the pancreas as a way to detect pancreatic cancer at an earlier stage.
Primary Outcome
Characterization of the proteomic signature of patients with pancreatic adenocarcinoma, pancreatic cancer, and control participants. This will be accomplished by classifying a group or set of similar proteomic profiles(once we(once we have developed from the samples obtained a list of known proteomic profiles taht are found in all pancreatic adenocarcinoma subjects) that are specific to the disease process,of pancreatic adenocarcinoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-04 |
What the finished NCT02277834 record still lists
NCT02277834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02277834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02277834 about?
NCT02277834 is a clinical study titled "Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice". Currently, X-rays and blood tests often miss pancreatic cancer. In this study, we are collecting and studying the fluid produced by the pancreas as a way to detect pancreatic cancer at an earlier stage.
What is the current status of trial NCT02277834?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2014-08. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT02277834?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia